These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15861932)

  • 1. Antifungal drugs and rational use of antifungals in treating invasive aspergillosis: the role of the hospital pharmacist.
    Bauters TG; Buyle FM; Peleman R; Robays H
    Pharm World Sci; 2005 Feb; 27(1):31-4. PubMed ID: 15861932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspofungin acetate for treatment of invasive fungal infections.
    Pacetti SA; Gelone SP
    Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antifungal combination therapy in invasive fungal infections].
    Gellen-Dautremer J; Lanternier F; Dannaoui E; Lortholary O
    Rev Med Interne; 2010 Jan; 31(1):72-81. PubMed ID: 19767130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Ruhnke M; Cornely OA; Schmidt-Hieber M; Alakel N; Boell B; Buchheidt D; Christopeit M; Hasenkamp J; Heinz WJ; Hentrich M; Karthaus M; Koldehoff M; Maschmeyer G; Panse J; Penack O; Schleicher J; Teschner D; Ullmann AJ; Vehreschild M; von Lilienfeld-Toal M; Weissinger F; Schwartz S
    Mycoses; 2020 Jul; 63(7):653-682. PubMed ID: 32236989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.
    Blyth CC; Hale K; Palasanthiran P; O'Brien T; Bennett MH
    Cochrane Database Syst Rev; 2010 Feb; 2010(2):CD006343. PubMed ID: 20166083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
    Salavert-Lletí M; Zaragoza-Crespo R
    Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan.
    Kung HC; Huang PY; Chen WT; Ko BS; Chen YC; Chang SC; Chuang YC; ; ; ;
    J Microbiol Immunol Infect; 2018 Feb; 51(1):1-17. PubMed ID: 28781150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical indications for newer antifungal agents.
    Naeger-Murphy N; Pile JC
    J Hosp Med; 2009 Feb; 4(2):102-11. PubMed ID: 19219926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comments on practice guidelines for the diagnosis and management of aspergillosis made by the IDSA in 2016.
    Alarcón-Manoja E; Cardozo-Espinola C; Puerta-Alcalde P; García-Vidal C
    Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():26-29. PubMed ID: 28882011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the current treatment of invasive fungal infection need to be reviewed?
    Martín-Peña A; Aguilar-Guisado M; Cisneros JM
    Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):523-8. PubMed ID: 23587702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal therapy in invasive fungal infections.
    Chen SC; Playford EG; Sorrell TC
    Curr Opin Pharmacol; 2010 Oct; 10(5):522-30. PubMed ID: 20598943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal clinical trials and guidelines: what we know and do not know.
    Pappas PG
    Cold Spring Harb Perspect Med; 2014 Nov; 4(11):a019745. PubMed ID: 25368017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic mycoses in the immunocompromised host: an update in antifungal therapy.
    Kontoyiannis DP; Mantadakis E; Samonis G
    J Hosp Infect; 2003 Apr; 53(4):243-58. PubMed ID: 12660121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
    Walsh TJ; Lutsar I; Driscoll T; Dupont B; Roden M; Ghahramani P; Hodges M; Groll AH; Perfect JR
    Pediatr Infect Dis J; 2002 Mar; 21(3):240-8. PubMed ID: 12005089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
    Spanakis EK; Aperis G; Mylonakis E
    Clin Infect Dis; 2006 Oct; 43(8):1060-8. PubMed ID: 16983621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Training should be the first step toward an antifungal stewardship program.
    Valerio M; Muñoz P; Rodríguez-González C; Sanjurjo M; Guinea J; Bouza E;
    Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):221-7. PubMed ID: 25066382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for polyenes in treating invasive mycoses?
    Cornely OA; Vehreschild JJ; Ullmann AJ
    Curr Opin Infect Dis; 2006 Dec; 19(6):565-70. PubMed ID: 17075332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing fungal infections in the intensive care unit.
    De Pauw BE
    Surg Infect (Larchmt); 2006; 7 Suppl 2():S93-6. PubMed ID: 16895517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic antifungal therapy: new options, new challenges.
    Wong-Beringer A; Kriengkauykiat J
    Pharmacotherapy; 2003 Nov; 23(11):1441-62. PubMed ID: 14620391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.